2024 Annual Meeting | C37 - Trigeminal Neuralgia: Mimics, Pharmacotherapy, and Surgical/Interventional Treatment

Date Sunday 04/14/24

Time 07:00 AM - 09:00 AM MDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Paul G. Mathew, MD, DNBPAS, FAAN, FAHS, FAAN

Topic(s) Headache

Learning Objectives Participants should be able to describe the pathophysiology of trigeminal neuralgia and potential neuroanatomical contributions; describe the diagnostic features of trigeminal neuralgia,; identify first- and second-line pharmacologic treatment options for trigeminal neuralgia; discuss therapeutic options for treating breakthrough attacks; describe the characteristics of odontogenic pain; identify the differences between TMD and odontogenic pain with trigeminal neuralgia; recognize the role of dentistry and the orofacial pain specialist in a multidisciplinary care model for trigeminal neuralgia; select optimal interventional techniques used for the treatment of refractory trigeminal neuralgia; and select optimal surgical techniques used for the treatment of trigeminal neuralgia.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice

Program Level Advanced

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student, Business Administrator

Teaching Styles Case-based, Didactic, Audience Participation

Program Evaluations

Event Timeline
07:00 AM - 07:35 AM MDT	Speaker	Pathophysiology, Diagnosis, Pharmacological Management of Trigeminal Neuralgia Payal P. Soni, MD
07:35 AM - 08:10 AM MDT	Speaker	Trigeminal Neuralgia Mimics: Headache and Orofacial Pain Differential Diagnosis and Management Marcela Romero-Reyes, DDS, PhD
08:10 AM - 08:45 AM MDT	Speaker	Interventional/Surgical Management of Trigeminal Neuralgia Paul G. Mathew, MD, DNBPAS, FAAN, FAHS, FAAN
08:45 AM - 09:00 AM MDT	Q&A	Panel Discussion Paul G. Mathew, MD, DNBPAS, FAAN, FAHS, FAAN, Payal P. Soni, MD, Marcela Romero-Reyes, DDS, PhD

Faculty Disclosures
Paul G. Mathew, MD, DNBPAS, FAAN, FAHS, FAAN	Dr. Mathew has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie/Allergan. Dr. Mathew has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Mathew has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven/Pfizer. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Upsher Smith. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Mathew has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie.
Payal P. Soni, MD	Dr. Soni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie.
Marcela Romero-Reyes, DDS, PhD	Marcela Romero-Reyes, DDS, PhD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Marcela Romero-Reyes, DDS, PhD has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Pain Medicine OUP.

��ɫ��

��ɫ��